Titan Medical Inc. Increase Decrease In Cash And Cash Equivalents
Titan Medical Inc. reported Increase Decrease In Cash And Cash Equivalents of -$20.67 million for the 9-month period ending 2022-09-30, per its 6-K filed 2022-11-10.
Discontinued › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2022-11-10
- Titan Medical Inc. increase decrease in cash and cash equivalents for the quarter ending 2022-09-30 was -$8.54M.
- Titan Medical Inc. increase decrease in cash and cash equivalents for the quarter ending 2022-06-30 was -$9.93M, a 707.52% decline year-over-year.
- Titan Medical Inc. increase decrease in cash and cash equivalents for the quarter ending 2022-03-31 was -$2.19M, a 107.86% decline year-over-year.
- Titan Medical Inc. increase decrease in cash and cash equivalents for the quarter ending 2021-12-31 was -$12.37M, a 1658.06% decline year-over-year.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 3 month as first filed | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 6 month as first filed | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 9 month as first filed | Increase Decrease In Cash And Cash Equivalents 12 month | Increase Decrease In Cash And Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$8.54M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-10 | -$18.48M derived: sum of 2 quarters · filed 2022-11-10 | -$20.67M 6-K · filed 2022-11-10 | -$33.04M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2022-06-30 | -$9.93M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-11 | -$12.13M 6-K · filed 2022-08-11 | -$24.50M derived: sum of 3 quarters · filed 2022-08-11 | -$34.83M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2022-03-31 | -$2.19M 6-K · filed 2022-05-12 | -$14.56M derived: sum of 2 quarters · filed 2022-05-12 | -$24.89M derived: sum of 3 quarters · filed 2022-11-10 | -$23.26M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-12-31 | -$12.37M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-24 | -$22.70M derived: sum of 2 quarters · filed 2022-11-10 | -$21.06M derived: sum of 3 quarters · filed 2022-11-10 | $6.84M 20-F · filed 2022-03-24 | ||||
| 2021-09-30 | -$10.33M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-10 | -$8.69M derived: sum of 2 quarters · filed 2022-11-10 | $19.21M 6-K · filed 2022-11-10 | $20.00M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $1.64M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-11 | $29.54M 6-K · filed 2022-08-11 | $30.33M derived: sum of 3 quarters · filed 2022-08-11 | $26.32M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $27.90M 6-K · filed 2022-05-12 | $28.70M derived: sum of 2 quarters · filed 2022-05-12 | $24.68M derived: sum of 3 quarters · filed 2022-05-12 | $51.61M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $794.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-24 | -$3.22M derived: sum of 2 quarters · filed 2022-03-24 | $23.71M derived: sum of 3 quarters · filed 2022-03-24 | $24.66M 20-F · filed 2022-03-24 | $24.65M 6-K · filed 2021-02-22 | |||
| 2020-09-30 | -$4.01M 6-K · filed 2020-11-16 | $22.92M derived: sum of 2 quarters · filed 2020-11-16 | $23.86M 6-K · filed 2021-11-12 | $23.86M 6-K · filed 2020-11-16 | $14.36M derived: sum of 4 quarters · filed 2022-03-24 | |||
| 2020-06-30 | $26.93M 6-K · filed 2020-08-12 | $27.88M 6-K · filed 2021-08-11 | $27.88M 6-K · filed 2020-08-12 | $18.37M derived: sum of 3 quarters · filed 2022-03-24 | $5.08M derived: sum of 4 quarters · filed 2022-03-24 | |||
| 2020-03-31 | $946.00K 6-K · filed 2021-05-17 | -$8.56M derived: sum of 2 quarters · filed 2022-03-24 | -$21.85M derived: sum of 3 quarters · filed 2022-03-24 | -$35.14M derived: sum of 4 quarters · filed 2022-03-24 | ||||
| 2019-12-31 | -$9.51M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-24 | -$22.80M derived: sum of 2 quarters · filed 2022-03-24 | -$36.09M derived: sum of 3 quarters · filed 2022-03-24 | -$10.66M 20-F · filed 2022-03-24 | -$10.66M 20-F · filed 2020-04-02 | |||
| 2019-09-30 | -$13.29M 6-K · filed 2020-11-16 | -$9.15M 6-K · filed 2019-11-15 | -$26.58M derived: sum of 2 quarters · filed 2020-11-16 | -$1.15M 6-K · filed 2020-11-16 | -$10.30M 6-K · filed 2019-11-15 | |||
| 2019-06-30 | -$13.29M 6-K · filed 2020-08-12 | -$1.15M 6-K · filed 2020-08-12 | ||||||
| 2018-12-31 | -$17.76M derived: 20-F 12 month − 6-K 9 month · filed 2020-04-02 | -$10.90M derived: sum of 2 quarters · filed 2020-04-02 | -$9.00M derived: sum of 3 quarters · filed 2020-04-02 | -$14.66M 20-F · filed 2020-04-02 | ||||
| 2018-09-30 | $6.86M 6-K · filed 2019-11-15 | $8.76M derived: sum of 2 quarters · filed 2019-11-15 | $3.10M 6-K · filed 2019-11-15 | |||||
| 2018-06-30 | $1.90M 6-K/A · filed 2019-09-30 | -$3.76M 6-K/A · filed 2019-09-30 | ||||||
| 2017-12-31 | $21.79M 20-F/A · filed 2020-04-02 |